Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival

Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival

Glioblastoma (GB) remains an aggressive malignancy with an extremely poor prognosis. Discovering new candidate drug targets for GB remains an unmet medical need. Caveolin-1 (Cav-1) has been shown to act variously as both a tumour suppressor and tumour promoter in many cancers. The implications of Ca...

Full description

Bibliographic Details
Main Authors: Chiara Moriconi, Prospero Civita, Catia Neto, Geoffrey J. Pilkington, Mark Gumbleton
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
caveolin-1
prognostic
survival
gender
TCGA
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.701933/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.701933/full

Similar Items